15,813 Shares in The Chemours Company (NYSE:CC) Purchased by Scientech Research LLC

Scientech Research LLC purchased a new stake in The Chemours Company (NYSE:CC) during the second quarter, according to its most recent disclosure with the SEC. The firm purchased 15,813 shares of the specialty chemicals company’s stock, valued at approximately $357,000.

Several other institutional investors also recently bought and sold shares of CC. New Covenant Trust Company N.A. purchased a new stake in shares of Chemours during the first quarter worth $29,000. North Star Investment Management Corp. grew its stake in Chemours by 1,510.0% during the 1st quarter. North Star Investment Management Corp. now owns 1,288 shares of the specialty chemicals company’s stock valued at $34,000 after acquiring an additional 1,208 shares in the last quarter. Sunbelt Securities Inc. raised its holdings in Chemours by 1,969.7% in the 1st quarter. Sunbelt Securities Inc. now owns 1,366 shares of the specialty chemicals company’s stock valued at $36,000 after acquiring an additional 1,300 shares during the last quarter. Neo Ivy Capital Management purchased a new position in Chemours in the 4th quarter worth approximately $40,000. Finally, Headlands Technologies LLC acquired a new position in shares of Chemours during the 1st quarter worth approximately $42,000. 76.26% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

CC has been the subject of several recent research reports. Mizuho began coverage on Chemours in a report on Friday, June 7th. They issued a “neutral” rating and a $25.00 price target for the company. UBS Group reduced their price target on Chemours from $30.00 to $28.00 and set a “buy” rating on the stock in a report on Tuesday, August 6th. BMO Capital Markets lowered their price target on shares of Chemours from $35.00 to $30.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 6th. Barclays cut their price objective on shares of Chemours from $22.00 to $21.00 and set an “equal weight” rating for the company in a research report on Wednesday, September 25th. Finally, The Goldman Sachs Group decreased their target price on shares of Chemours from $29.00 to $23.00 and set a “neutral” rating on the stock in a report on Tuesday, September 3rd. Six investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $26.63.

Chemours Price Performance

Shares of CC opened at $20.72 on Monday. The firm has a 50-day simple moving average of $19.57 and a two-hundred day simple moving average of $23.65. The stock has a market cap of $3.09 billion, a PE ratio of -9.55 and a beta of 1.74. The Chemours Company has a 1-year low of $15.10 and a 1-year high of $32.70. The company has a debt-to-equity ratio of 5.45, a current ratio of 1.89 and a quick ratio of 1.01.

Chemours (NYSE:CC) last announced its earnings results on Thursday, August 1st. The specialty chemicals company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.57 by ($0.19). Chemours had a net margin of 2.16% and a return on equity of 33.21%. The firm had revenue of $1.54 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period in the previous year, the firm earned $1.10 EPS. The firm’s revenue for the quarter was down 6.4% compared to the same quarter last year. As a group, analysts forecast that The Chemours Company will post 1.33 EPS for the current year.

Chemours Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 13th. Shareholders of record on Thursday, August 15th were given a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 4.83%. The ex-dividend date of this dividend was Thursday, August 15th. Chemours’s dividend payout ratio is currently -46.08%.

About Chemours

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.